Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

781 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.
Frey SE, Houghton M, Coates S, Abrignani S, Chien D, Rosa D, Pileri P, Ray R, Di Bisceglie AM, Rinella P, Hill H, Wolff MC, Schultze V, Han JH, Scharschmidt B, Belshe RB. Frey SE, et al. Among authors: rosa d. Vaccine. 2010 Aug 31;28(38):6367-73. doi: 10.1016/j.vaccine.2010.06.084. Epub 2010 Jul 7. Vaccine. 2010. PMID: 20619382 Free PMC article. Clinical Trial.
Perspectives for a hepatitis C virus vaccine.
Abrignani S, Rosa D. Abrignani S, et al. Among authors: rosa d. Clin Diagn Virol. 1998 Jul 15;10(2-3):181-5. doi: 10.1016/s0928-0197(98)00028-2. Clin Diagn Virol. 1998. PMID: 9741644 Review.
HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial.
Colombatto P, Brunetto MR, Maina AM, Romagnoli V, Almasio P, Rumi MG, Ascione A, Pinzello G, Mondelli M, Muratori L, Rappuoli R, Rosa D, Houghton M, Abrignani S, Bonino F. Colombatto P, et al. Among authors: rosa d. J Viral Hepat. 2014 Jul;21(7):458-65. doi: 10.1111/jvh.12163. Epub 2013 Aug 27. J Viral Hepat. 2014. PMID: 24750327 Free PMC article. Clinical Trial.
A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells.
Rosa D, Campagnoli S, Moretto C, Guenzi E, Cousens L, Chin M, Dong C, Weiner AJ, Lau JY, Choo QL, Chien D, Pileri P, Houghton M, Abrignani S. Rosa D, et al. Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):1759-63. doi: 10.1073/pnas.93.5.1759. Proc Natl Acad Sci U S A. 1996. PMID: 8700831 Free PMC article.
Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.
Heile JM, Fong YL, Rosa D, Berger K, Saletti G, Campagnoli S, Bensi G, Capo S, Coates S, Crawford K, Dong C, Wininger M, Baker G, Cousens L, Chien D, Ng P, Archangel P, Grandi G, Houghton M, Abrignani S. Heile JM, et al. Among authors: rosa d. J Virol. 2000 Aug;74(15):6885-92. doi: 10.1128/jvi.74.15.6885-6892.2000. J Virol. 2000. PMID: 10888628 Free PMC article.
Binding of hepatitis C virus to CD81.
Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S. Pileri P, et al. Among authors: rosa d. Science. 1998 Oct 30;282(5390):938-41. doi: 10.1126/science.282.5390.938. Science. 1998. PMID: 9794763
781 results